GeneDx Holdings(WGS)

POST107.90-0.18-0.17%18:46 EST

108.08-1.20-1.10%

CommunityCommunity
NewsNews
ProfileProfile
AnnouncementsAnnouncements

Company Profile
Company Name
GeneDx Holdings
Market
NASDAQ
Establishment Date
- -
Employees
- -
Office Location
- -
Website
http://ir.genedx.com
Zip Code
- -
Phone
- -
Fax
- -
Introduction
GeneDx Holdings Corp., through its subsidiaries, provides genomics-related diagnostic and information services. The company offers Centrellis, an AI-driven health intelligence platform that integrates digital tools and artificial intelligence allowing scientists to ingest and synthesize clinical and genomic data to deliver comprehensive health insights. It also provides genetic diagnostic tests, screening solutions, and information with a focus on pediatrics, rare diseases for children and adults, and hereditary cancer screening. GeneDx Holdings Corp. is headquartered in Stamford, Connecticut.
- 01-12
  Major Issues Report
  Form 8-K - Current report
  Form 8-K - Current report
- 2025-11-25
  Proposed Sale Of Securities
  Form 144 - Report of proposed sale of securities
  Form 144 - Report of proposed sale of securities
- 2025-10-28
  Quarterly Report
  Form 10-Q - Quarterly report [Sections 13 or 15(d)]
  Form 10-Q - Quarterly report [Sections 13 or 15(d)]
- 2025-10-28
  Major Issues Report
  Form 8-K - Current report
  Form 8-K - Current report
- 2025-09-30
  Proposed Sale Of Securities
  Form 144 - Report of proposed sale of securities
  Form 144 - Report of proposed sale of securities
- 2025-09-30
  Proposed Sale Of Securities
  Form 144 - Report of proposed sale of securities
  Form 144 - Report of proposed sale of securities
- 2025-09-18
  Major Issues Report
  Form 8-K - Current report
  Form 8-K - Current report
- 2025-08-27
  Proposed Sale Of Securities
  Form 144 - Report of proposed sale of securities
  Form 144 - Report of proposed sale of securities
- 2025-08-22
  Proposed Sale Of Securities
  Form 144 - Report of proposed sale of securities
  Form 144 - Report of proposed sale of securities
- 2025-07-29
  Quarterly Report
  Form 10-Q - Quarterly report [Sections 13 or 15(d)]
  Form 10-Q - Quarterly report [Sections 13 or 15(d)]
- 2025-07-29
  Major Issues Report
  Form 8-K - Current report
  Form 8-K - Current report
- 2025-07-17
  Correspondence
  Form CORRESP - Correspondence
  Form CORRESP - Correspondence
- 2025-07-01
  Proposed Sale Of Securities
  Form 144 - Report of proposed sale of securities
  Form 144 - Report of proposed sale of securities
- 2025-07-01
  Proposed Sale Of Securities
  Form 144 - Report of proposed sale of securities
  Form 144 - Report of proposed sale of securities
- 2025-06-18
  Major Issues Report
  Form 8-K - Current report
  Form 8-K - Current report

Side	Reported Price \| Filled	Portfolio changes
Buy Increase	109.28 2,940	+1.43% Holding

Side	Reported Price \| Filled	Portfolio changes
Buy Increase	104.56 3,328	+0.71% Holding

Side	Reported Price \| Filled	Portfolio changes
Buy Increase	109.84 2,560	+0.55% Holding

Side	Reported Price \| Filled	Portfolio changes
Buy Increase	119.24 114,459	+32.84% Holding

Side	Reported Price \| Filled	Portfolio changes
Buy Increase	119.24 20,257	+10.88% Holding

Side	Reported Price \| Filled	Portfolio changes
Sell Decrease	135.38 2,328	-0.66% Holding

1D
5D
Day
Week
Month

Loading ...

High

113.23

Open

108.97

Volume%

0.64

Low

106.71

109.28

T/O Rate

3.54%

To The Moon

GeneDx Holdings(WGS)

Company Profile

Most Discussed